1. Field of the Invention
The present invention relates generally to optical systems and methods for biological samples, and more specifically to optical systems and methods for fluorescence imaging of two-dimensional distributions of biomolecular samples.
2. Description of the Related Art
Fluorescence readers and imaging devices are used in the identification of various biomolecular substances such as protein, DNA, or RNA molecules. Samples containing such molecules may be prepared according to various known procedures, protocols, or assays. Molecules within the samples may be detected, analyzed, and/or differentiated using various light-absorptive, radioactive, luminescent, or fluorescent compounds known in the art. For example, one or more fluorophores, such as fluorescent probe, dyes, markers, may be added to the sample to produce fluorescent signals or images indicative of the presence or amount of one or more target molecules.
Procedures for detecting or imaging may include attachment of reporter moieties to separated species. Examples of such procedures include the use of blotting membranes. Depending of the type of biomolecule of interest “Southern,” “Northern,” and “Western” blotting procedures may be used. For example, a Western blot is typically used in detecting or measuring protein molecules.
Typical instruments are expensive and complex. Systems and methods are needed that allow experimental results with minimal training. Additionally, low cost systems are needed to allow proliferation of these techniques to bench-top users. Quantum dot systems are attractive, but currently suffer from lack of a dedicated, low-cost device for Western blot detection and cellular analysis. Thus, simple and inexpensive Western blot systems and methods are also needed.
Aspects, features, and advantages of the present invention are set forth in the following description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numbers. Embodiments of the present invention may be better understood from the following detailed description when read in conjunction with the accompanying drawings. Such embodiments, which are for illustrative purposes only, depict novel and non-obvious aspects of the invention. The drawings include the following figures:
Embodiments of the present invention are generally directed to systems and methods for obtaining fluorescent data from samples containing one or more fluorescent dyes, markers, or probes. Such embodiments may incorporate imaging systems or instruments to record fluorescent images of substrate including protein, DNA, and/or RNA molecules, or the like. In certain embodiments, the systems and methods involve a sample substrate suitable for use blot methods for detecting and measuring proteins, DNA, and/or RNA. Examples include, but are not limited to Western blot, Southern blot, Northern blot, Eastern blot, Southwestern blot, reverse Northern blot, Far-Western or Far-Eastern blot, Dot blot, Slot blot, or the like.
Referring to
Computer 118 may include electronic memory storage containing instructions, routines, algorithms, test and/or configuration parameter, test or experimental data, or the like. Computer 118 may be configured, for example, to operate various components of the optical system or to obtain and/or process data provided by system 100. For example, computer 118 may be used to obtain and/or process optical data provided by photodetector 114. In certain embodiments, computer 118 may communicate with additional external computer and/or transmit data to an external computer for further processing, for example, using a hardwire connection, a local area network, an internet connection, cloud computing system, or the like. Computer 118 may be physical computer, such as a desktop computer, laptop computer, notepad computer, tablet computer, or the like. Additionally or alternatively, computer 118 may comprise a virtual device or system such as a cloud computing or storage system. Data may be transferred or shared between computers 118 and an external computer via a wireless connection within a local area network, a cloud storage or computing system, or the like. Additionally or alternatively, data from system 100 may be transferred to an external memory storage device, for example, an external hard drive, a USB memory module, a cloud storage system, or the like.
Enclosure 106 may be configured to support or hold samples 104, for example, by providing a floor, base, stage, pedestal, or the like within enclosure 106. Samples 104 may also be contained on or within a sample holder 120 that include an active area 122 and that is supported or held within enclosure 106. As used herein, the term “active area” refers to a portion or area of a sample holder containing one or more samples for which images and/or information is to be obtained. Sample holder 120 may comprise a substrate, gel, membrane, or other structure or material suitable for holding or maintaining samples 104.
In certain embodiments, one or more of the samples 104 include fluorophore, such a fluorescent probe, fluorescent dye, fluorescent marker, or the like. For example, one or more of the samples 104 may comprise a first fluorescent probe characterized by a first excitation wavelength (or wavelength band) and a first emission wavelength (or wavelength band) and a second fluorescent probe characterized by a second excitation wavelength (or wavelength band) and a second emission wavelength (or wavelength band). In certain embodiments, any or all of the characteristic wavelengths may be an average or median wavelength of a wavelength band, or a wavelength at which the value is the maximum over a wavelength band. Each fluorescent probe may be configured to be activated or provide increased fluorescence when bound to a predetermined chemical sequence corresponding to each fluorescent probe is present within samples 104. The predetermined chemical sequences may include one more of a polynucleotide, an amino acid sequence, a DNA sequence, an RNA sequence, or the like. The sample may further comprise additional fluorescent probes, or the like, where each fluorescent probe may be configured to be activated or provide increased fluorescence when bound to a predetermined chemical sequence corresponding to each fluorescent probe is present within samples 104. The predetermined chemical sequences may include only one type of sequence (e.g., comprise only amino acid sequences, only DNA sequences, or only RNA sequences) or may include a combination of different types of sequences (e.g., one or more amino acid sequences and one or more DNA and/or RNA sequences). In certain embodiments, one or more of the samples 104 include one or more types of nanocrystal probe materials or quantum dot probe materials. These materials may be used as an alternative to, or in addition to, the fluorescent probes discussed in the paragraphs above. Advantageously, such material may be used to increase the flexibility and/or signal strength when used in the various applications discussed above in relation to more traditional fluorophores.
In certain embodiments, sample holder 120 comprises a blotting membrane or substrate, or similar structure, for use in a blotting assay that includes a fluorophore, nanocrystal, quantum dot, and/or other fluorescent dye or probe. In such embodiments, samples 104 may include one or more target peptide or proteins sequences and active area 122 may comprise a protein immunoblot, Western blot, or dot blot. Additionally or alternatively, samples 104 may include one or more target DNA and/or RNA sequences and/or active area 122 may comprise a Southern blot, a Northern blot, an Eastern blot, or the like.
As shown in the illustrated embodiment of
Light source 108 comprises electromagnetic radiation in a wavelength band suitable of exciting fluorescent dyes or probes contained in samples 104. As used herein, the term “light source” means any source of electromagnetic radiation in the visible waveband, the UV waveband, the near infrared waveband, and/or the infrared waveband. Examples of light sources include, but are not limited to, light emitting diodes (LEDs), lasers, Xenon lamps, halogen lamps, mercury lamps, UV lamps, and/or incandescent lamps. As shown in the illustrated embodiment of
Photodetector 114 may comprise a two dimensional segmented or pixilated detector array. For example, photodetector 114 may comprise a two-dimensional charge coupled device (CCD) detector or a two-dimensional complementary metal-oxide-semiconductor (CMOS) detector. Photodetector 114 is configured to receive one or more images produced by one or more fluorescent dyes or probes contained in samples 104.
In addition to beamsplitter 112, optical system 110 may further comprises one or more lenses 142 configured to image active area 122 onto photodetector 114 and at least one emission optical filter 144 that may be configured to filter excitation light from light source 108. The elements of optical system 110 that are located between samples 104 and photodetector 114 are disposed along a second optical axis 148, which is perpendicular to first optical axis 140 in the illustrated embodiment.
Optical filter 144 may comprise an optical characteristic that is highly transmissive of light at the emission wavelength of one or more of the fluorescent dyes or probes contained in samples 104. For example, optical filter 144 may have a transmittance that is at least 90 percent, at least 99 percent, or at least 99.9 percent over the emission wavelengths produced by one more of the fluorescent dyes or probes contained in samples 104. The optical characteristic of optical filter 144 may simultaneously be highly reflective and/or highly absorptive of light at other wavelengths (e.g., highly reflective or absorptive at all or most of the wavelength emitted by light source 108). For example, optical filter 144 may have a reflectance or absorptivity that is at least 90 percent, at least 95 percent, at least 99 percent, or at least 99.9 percent of light outside the emission wavelength of one more of the fluorescent dyes or probes contained in samples 104. Optical filter 144 may have an optical characteristic that is highly transmissive of the emission wavelengths of two or more of the fluorescent dyes or probes contained in samples 104. For example, optical filter 144 may have a transmittance that is at least 90 percent, at least 95 percent, at least 99 percent, or at least 99.9 percent over the emission wavelengths produced by two or more of the fluorescent dyes or probes contained in samples 104. Alternatively, optical filter 144 may have an optical characteristic that is highly transmissive of the emission wavelength only one of the fluorescent dyes or probes contained in samples 104. In such embodiments, the optical system may comprise a plurality of emission optical filters 144 that may be moved into and out of the optical path of emission light from samples 104. In such embodiments, a sequence of images of the samples 104 may be recorded using photodetector 114, where different images record different ones of the fluorescent dyes or probes contained in samples 104 or different sets of the fluorescent dyes or probes contained in samples 104.
In the illustrated embodiment shown in
In certain embodiment, light source 108 and samples 104 directly face one another and are located on opposite sides of beamsplitter 112. In such embodiments, samples 104 are configured so that fluorescent light from samples 104 are reflected off beamsplitter 112 and to detector 114. It will be appreciated that in such embodiments, beamsplitter 112 may comprise an optical characteristic that is highly reflective of light at the emission wavelengths of the fluorescent dyes or probes contained in samples 104. In addition, the optical characteristic of beamsplitter 112 in this case may be highly transmissive of light at wavelengths corresponding to the wavelength band or profile of light source 108 and/or highly transmissive of light at wavelengths suitable for excitation of fluorescent dyes or probes contained in sample 104.
In certain embodiments, light source 108 is a single color source (e.g., a single color LED or laser) and/or has a relatively narrow wavelength band (e.g., has a bandwidth that is less than or equal to 100 nanometers, less than or equal to 50 nanometers, or less than or equal to 10 nanometers). In such embodiments, samples 104 may include two or more types of quantum dot dyes or probe that have the same or nearly the same excitation wavelength. For example, samples 104 may each comprise a first quantum dot with an excitation wavelength of 390 nanometers and an emission wavelength of 625 nanometer, and a second quantum dot with an excitation wavelength also of 390 nanometers, but an emission wavelength of 800 nanometer. A single excitation filter 144 may be used to pass emission light from both quantum dots, for example, having a transmittance that is greater than 95 percent over a wavelength band from 600 nanometers to 850 nanometers and having a transmittance of less than 1 percent at a wavelength of 390 nanometers (e.g., having a transmittance of less than 1 percent at wavelengths less than 600 nanometers). In such embodiments, beamsplitter 112 may have a high reflectivity at wavelengths equal to the excitation wavelength of the quantum dots (e.g., having a reflectivity of at least 95 percent or at least 99 percent over a wavelength range of 360 nanometers to 420 nanometers, or having a reflectivity of at least 95 percent or at least 99 percent at wavelengths less than 600 nanometers) and highly transmissive of light at the emission wavelengths of the quantum dots (e.g., highly transmissive at wavelengths greater than or equal to 600 nanometers).
Referring to
Referring to
For Qdot detection, 395 nanometers emitting LEDs were installed as the excitation light source with a 420 nanometers band-pass dichroic mirror and emission filters filtering at 625 nanometers and 800 nanometers. A serial dilution of bovine serum albumin (200 ng-780 pg) was separated on 3 polyacrylamide electrophoresis gels (SDS-PAGE), and respectively blotted to 3 nitrocellulose membranes. Following, an immunodetecion process took place using rabbit anti-BSA. Each membrane was labeled with a) 625 nanometers, b) 800 nanometers fluorescence emitting anti-rabbit quantum dot-conjugated antibody, and c) a control membrane labeled with an HRP conjugated anti-rabbit antibody. The Qdot labeled membranes were exposed in the experimental imager for 2 seconds and the HRP labeled membrane was exposed to film for 60 seconds. Both methods yielded equal detection levels as low as 0.4 ng of BSA. Additional experiments (data not shown) show that imaging the described Qdot labeled membranes with a Fuji LAS-3000 yielded only a 2 fold more sensitive detection at a 2 minute exposure time than to the same membranes imaged in the experimental device at a 2 second exposure time. The membrane shown in
For DNA quantification, a 480 nanometers LED source was used with a 505 nanometers band-pass dichroic minor and an emission filter at 530 nanometers. Serial dilutions of DNA samples were quantified using the Qubit® Fluorometer (HS and BR kits manufactured by Invitrogen, Carlsbad, Calif.), then plated in a 96 well microtiter plate and imaged using the experimental imaging system. The DNA concentrations were calculated by image analysis densitometry. The method allowed batch analysis of multiple samples with accurate results and with a correlation of R̂2=0.982 for samples analyzed by image analysis and an R̂2=0.961 for samples analyzed by Qubit®.
Referring to the results shown in
In one embodiment, the modular use of LEDs, dichroic minors and filters in a large scale system which was previously used mainly in microscopy. The modularity of the LED-FILTER and dichroic minor as a unit is also new.
The above presents a description of the best mode contemplated of carrying out the present invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains to make and use this invention. This invention is, however, susceptible to modifications and alternate constructions from that discussed above which are fully equivalent. Consequently, it is not the intention to limit this invention to the particular embodiments disclosed. On the contrary, the intention is to cover modifications and alternate constructions coming within the spirit and scope of the invention as generally expressed by the following claims, which particularly point out and distinctly claim the subject matter of the invention.
The present application claims priority under 35 U.S.C §119(e) to provisional application No. 61/644,968, filed on May 9, 2012, the entire contents of which are hereby incorporated by reference in its entirety for all purposes as if fully set forth herein.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2013/040424 | 5/9/2013 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61644968 | May 2012 | US |